The retrial of the Fosamax/osteonecrosis of the jaw (ONJ) trial that ended in a mistrial last year got under way June 7 in the U.S. District Court for the Southern District of New York. The lawsuit ...
The U.S. Supreme Court on Monday denied a petition for a writ of certiorari filed by the drug company Merck Sharp & Dohme Corp., bringing to a close a decade-long legal battle that had stalled ...
(CN) - A Manhattan federal judge dismissed a Mississippi woman's lawsuit against Merck & Co., who claimed the osteoporosis drug Fosamax caused her jaw damage. The dismissal comes two months after ...
A federal judge overseeing consolidated litigation against Merck & Co over jaw injuries allegedly caused by the osteoporosis drug Fosamax has ordered hundreds of cases be dispersed to courts across ...
A new trial is scheduled to begin June 2 for the Fosamax/osteonecrosis of the jaw (ONJ) case that ended in a mistrial last September, according to a story on aboutlawsuits.com. The lawsuit involves a ...
Two recent reports have linked the osteoporosis drug alendronate (Fosamax) with rare but serious side effects. In a letter to the New England Journal of Medicine published Jan. 1, a Food and Drug ...
NEW YORK--(BUSINESS WIRE)-- Kent Klaudt of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP announced that Reba Inez Patton and her husband Patrick Patton of Tennessee have ...
PHILADELPHIA (CN) - In a sweeping reversal against the drugmaker Merck, the Third Circuit revived hundreds of class actions by people whose thigh bones shattered while they were taking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results